NCT05843045Completed
Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma
Indoor Air Quality Asthma Study: A Cooperative Study Between Coepland LP, Cairify, and Dayton Children's Hospital to Determine the Effect of Indoor Air Quality and Mitigation of Indoor Air Quality on Persistent Asthma
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 6 Mar 2023
- Start date
- 18 Aug 2023
- Primary completion date
- 9 Jan 2024
- Lead sponsor
- Dayton Children's Hospital
- Diseases
- Asthma
- NCT number
- NCT05843045
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 18 Aug 2023 to the primary completion date, 9 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Exclusion criteria: Age \<5.0 or \>15.9 years at the time of informed consent, inability to commit to being in the same home for the length of the study, and/or not meeting the above inclusion criteria.
Who the study is looking for
- Child aged 5.0-15.9 years at the time of informed consent with mild, moderate, or severe persistent asthma diagnosis. In addition, participants
- Agree to attend visits as outlined by protocol
- Agree to respond to Asthma Control Test (ACT) and asthma control questions as outlined in protocol by telephone call, text, or email.
- Are willing to comply with asthma treatment plan prescribed by physician.
- Are willing to practice an acceptable form of birth control to avoid pregnancy. Acceptable forms of birth control include: true abstinence, male or female condom with or without spermicide, female barrier contraception (such as diaphragm, cervical cap, or sponge) with spermicide, continuous use of an intrauterine device throughout the study, hormonal contraceptives (including oral, patch, implanted, or injected), if used consistently and correctly throughout the study.
- Reside in single-family dwellings and must either be homeowners or have written permission from their landlords to participate in the study.
- In order to participate in the study, homes of participants must
- have working ducted forced air HVAC systems
- a 4-wire thermostat that is determined by Emerson technician to be capable of communicating with Sensi Touch Smart Thermostat
- a bathroom fan switch with neutral wire and wall plate, controlling a bathroom fan that is vented to the outdoors
- access to the internet with a modem or router.
- A smartphone capable of pairing with the Atmotube Pro wearable sensor
Age in the registry: 5 years to 15 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dayton Childrens Hospital Coordinator of this site? Confirm its status | Dayton | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.